| Date | Time | Source | Headline | Symbol | Company |
| 03/02/2012 | 11:05AM | Zacks | Shire and arGEN-X Ink Deal - Analyst Blog | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 03/01/2012 | 9:00AM | Business Wire | Impax Laboratories to Present at the Cowen and Company Health Care Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/28/2012 | 4:43PM | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/28/2012 | 9:29AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/28/2012 | 7:00AM | Business Wire | Impax Laboratories Fourth Quarter 2011 EPS Increases 74% to $0.33 | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/24/2012 | 9:30AM | Business Wire | Impax Laboratories to Present at the RBC Capital Markets’ Healthcare Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/23/2012 | 7:00AM | Business Wire | FDA Accepts Impax Pharmaceuticals NDA Filing for IPX066 for the Treatment of Idiopathic Parkinson’s Disease | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/15/2012 | 4:53PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/13/2012 | 12:23PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/09/2012 | 7:00AM | Business Wire | Impax Laboratories Provides Update on Status of Warning Letter Resolution for its Hayward Facility | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/07/2012 | 9:45AM | Zacks | Shire and Sangamo Cut a Deal - Analyst Blog | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/06/2012 | 5:07PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/01/2012 | 9:04AM | Dow Jones News | Impax Gains Rights For US Sales Of Zomig; Paying $130 Million In 2012 | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/01/2012 | 8:00AM | Business Wire | Impax Pharmaceuticals Licenses Exclusive U.S. Commercialization Rights to Zomig® (zolmitriptan) from AstraZeneca | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/30/2012 | 10:00AM | Zacks | Perrigo Files for Generic Astepro - Analyst Blog | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/26/2012 | 9:15AM | Business Wire | Impax Laboratories Schedules Conference Call and Webcast for Fourth Quarter and Full Year 2011 Financial Results | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/23/2012 | 8:49AM | PR Newswire (US) | Perrigo Confirms Filing for Generic Version of Astepro® Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda ... | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/16/2012 | 11:43AM | Zacks | Shire, Prasco Ink Deal - Analyst Blog | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/09/2012 | 5:01PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/04/2012 | 9:30AM | Business Wire | Impax Laboratories to Present at the J.P. Morgan Healthcare Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/22/2011 | 2:56PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/21/2011 | 8:30AM | Business Wire | Impax Pharmaceuticals Submits New Drug Application for IPX066 in Parkinson’s Disease | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/19/2011 | 11:30AM | Business Wire | Impax Pharmaceuticals Initiates Phase IIb Trial of IPX159 in Restless Legs Syndrome | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 11/23/2011 | 11:00AM | Business Wire | Impax Laboratories to Present at the Piper Jaffray 23rd Annual Healthcare Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 11/21/2011 | 8:30AM | Business Wire | Impax Laboratories Confirms Patent Challenge Relating to Generic FENTORA® | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 11/17/2011 | 6:16PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 11/09/2011 | 8:00AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 11/07/2011 | 9:30AM | Business Wire | Impax Laboratories to Present at the Credit Suisse 2011 Healthcare Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 11/03/2011 | 4:13PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 11/01/2011 | 5:11PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |